These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Discrepant in vitro versus in vivo interaction of M-positive donor red cells with IgG1 anti-M. Branch DR, McBroom R, Jones GL. Rev Fr Transfus Immunohematol; 1983 Dec; 26(6):565-72. PubMed ID: 6675157 [Abstract] [Full Text] [Related]
43. An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitization in ABO haemolytic disease of the newborn and observations on pinocytosis of IgG anti-A antibodies by infant (cord) red cells. Voak D, Williams MA. Br J Haematol; 1971 Jan; 20(1):9-23. PubMed ID: 5099693 [No Abstract] [Full Text] [Related]
44. Characterization of an anti-Dia antibody causing hemolytic disease in a newborn infant. Alves de Lima LM, Berthier ME, Sad WE, DiNapoli J, Johnson CL, Marsh WL. Transfusion; 1982 Jan; 22(3):246-7. PubMed ID: 7090038 [Abstract] [Full Text] [Related]
45. Experience with the routine use of an abbreviated crossmatch. Shulman IA, Nelson JM, Saxena S, Thompson JC, Okamoto M, Kent DR, Nakayama RK. Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079 [Abstract] [Full Text] [Related]
46. Positive direct antiglobulin tests at birth without demonstrable maternal antibody. Marsh WL, Mawby LJ, Mueller KA, Hall JW, Colucci J. Transfusion; 1984 Aug; 24(1):19-21. PubMed ID: 6695435 [Abstract] [Full Text] [Related]
49. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Vamvakas EC, Pineda AA, Reisner R, Santrach PJ, Moore SB. Transfusion; 1995 Jan; 35(1):26-32. PubMed ID: 7998064 [Abstract] [Full Text] [Related]
50. Evidence that the human blood group antigens Gya and Hy are carried on a novel glycosylphosphatidylinositol-linked erythrocyte membrane glycoprotein. Spring FA, Reid ME. Vox Sang; 1991 Jan; 60(1):53-9. PubMed ID: 1828922 [Abstract] [Full Text] [Related]
51. The serology of the York-Cost-McCoy-Knops red blood cell system. Molthan L. Am J Med Technol; 1983 Jan; 49(1):49-56. PubMed ID: 6846382 [Abstract] [Full Text] [Related]
53. The significance of complement in immunohematology. Garratty G. Crit Rev Clin Lab Sci; 1984 Jan; 20(1):25-56. PubMed ID: 6373144 [Abstract] [Full Text] [Related]
54. Studies on the blood of a Co (a-b-) proposita and her family. Lacey PA, Robinson J, Collins ML, Bailey DG, Evans CC, Moulds JJ, Daniels GL. Transfusion; 1987 Jan; 27(3):268-71. PubMed ID: 3590290 [Abstract] [Full Text] [Related]
55. Reduced survival of isotope-labelled Rh(D)-negative donor red cells in a patient with anti-LWab. Herron R, Bell A, Poole J, Clark M, Smith DS, Hamblin TJ. Vox Sang; 1986 Jan; 51(4):314-7. PubMed ID: 3099473 [Abstract] [Full Text] [Related]
56. Hemolytic disease of the newborn associated with anti-Jk3. Pierce SR, Hardman JT, Steele S, Beck ML. Transfusion; 1980 Jan; 20(2):189-91. PubMed ID: 7368267 [Abstract] [Full Text] [Related]
57. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel? Vox Sang; 1982 Jan; 43(3):151-68. PubMed ID: 6815895 [No Abstract] [Full Text] [Related]